Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 10 de 10
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Sci Rep ; 12(1): 5163, 2022 03 25.
Article de Anglais | MEDLINE | ID: mdl-35338218

RÉSUMÉ

PCNA is a central orchestrator of cellular processes linked to DNA metabolism. It is a binding platform for a plethora of proteins and coordinates and regulates the activity of several pathways. The outer side of PCNA comprises most of the known interacting and regulatory surfaces, whereas the residues at the inner side constitute the sliding surface facing the DNA double helix. Here, by investigating the L154A mutation found at the inner side, we show that the inner surface mediates protein interactions essential for genome stability. It forms part of the binding site of Rad18, a key regulator of DNA damage tolerance, and is required for PCNA sumoylation which prevents unscheduled recombination during replication. In addition, the L154 residue is necessary for stable complex formation between PCNA and the replicative DNA polymerase δ. Hence, its absence increases the mutation burden of yeast cells due to faulty replication. In summary, the essential role of the L154 of PCNA in guarding and maintaining stable replication and promoting DNA damage tolerance reveals a new connection between these processes and assigns a new coordinating function to the central channel of PCNA.


Sujet(s)
DNA polymerase III , Antigène nucléaire de prolifération cellulaire/métabolisme , Protéines de Saccharomyces cerevisiae/métabolisme , ADN/métabolisme , Altération de l'ADN , DNA polymerase III/génétique , DNA polymerase III/métabolisme , Réplication de l'ADN/génétique , Protéines de liaison à l'ADN/génétique , Instabilité du génome , Humains , Saccharomyces cerevisiae/génétique , Saccharomyces cerevisiae/métabolisme , Ubiquitin-protein ligases/métabolisme
2.
J Mol Biol ; 434(5): 167437, 2022 Mar 15.
Article de Anglais | MEDLINE | ID: mdl-34990655

RÉSUMÉ

Genomic stability is compromised by DNA damage that obstructs replication. Rad5 plays a prominent role in DNA damage bypass processes that evolved to ensure the continuation of stalled replication. Like its human orthologs, the HLTF and SHPRH tumor suppressors, yeast Rad5 has a RING domain that supports ubiquitin ligase activity promoting PCNA polyubiquitylation and a helicase domain that in the case of HLTF and Rad5 was shown to exhibit an ATPase-linked replication fork reversal activity. The RING domain is embedded in the helicase domain, confusing their separate investigation and the understanding of the exact role of Rad5 in DNA damage bypass. Particularly, it is still debated whether the helicase domain plays a catalytic or a non-enzymatic role during error-free damage bypass and whether it facilitates a function separately from the RING domain. In this study, through in vivo and in vitro characterization of domain-specific mutants, we delineate the contributions of the two domains to Rad5 function. Yeast genetic experiments and whole-genome sequencing complemented with biochemical assays demonstrate that the ubiquitin ligase and the ATPase-linked activities of Rad5 exhibit independent catalytic activities in facilitating separate pathways during error-free lesion bypass. Our results also provide important insights into the mutagenic role of Rad5 and indicate its tripartite contribution to DNA damage tolerance.


Sujet(s)
Altération de l'ADN , Helicase , Instabilité du génome , Protéines de Saccharomyces cerevisiae , Saccharomyces cerevisiae , Catalyse , Helicase/composition chimique , Helicase/génétique , Helicase/métabolisme , Réplication de l'ADN , Humains , Domaines protéiques , Saccharomyces cerevisiae/enzymologie , Saccharomyces cerevisiae/génétique , Protéines de Saccharomyces cerevisiae/génétique , Protéines de Saccharomyces cerevisiae/métabolisme , Ubiquitine/métabolisme , Ubiquitin-protein ligases/génétique , Ubiquitin-protein ligases/métabolisme
3.
Anticancer Res ; 41(11): 5549-5556, 2021 Nov.
Article de Anglais | MEDLINE | ID: mdl-34732425

RÉSUMÉ

BACKGROUND/AIM: LUCAS is a clinical lung cancer registry (ClinicalTrials.gov identifier is NCT04228237), prospectively collecting data from newly diagnosed lung cancer patients in seven pneumooncology centers in the Czech Republic, since June 1, 2018. The aim of the study was to assess the stage of the disease at the time of diagnosis, percentage of morphological types, survival, percentage of driving mutations, eligibility for radical surgery, and percentage of patients who undergo radical surgery, in the non-smoking population in comparison with smokers and former smokers. PATIENTS AND METHODS: The total number of patients in the registry at the time of the analysis was 2,743. Only 2,439 patients with complete records (smoking status, stage, and type of tumor) were included in this study. RESULTS: The analysis indicated that non-smokers are diagnosed at a later stage of the disease but they have a better survival rate than smokers. Fewer smokers with stage III disease who are eligible for radical surgery will undergo surgery compared to non-smokers with the same clinical stage. Driving mutations are more common in non-smokers, even after adjustment for the more frequent occurrence of adenocarcinoma in the group of non-smokers. CONCLUSION: The data from LUCAS registry are consistent with already known facts, suggesting that the LUCAS registry is a useful clinical tool.


Sujet(s)
Carcinome pulmonaire non à petites cellules/épidémiologie , Tumeurs du poumon/épidémiologie , Non-fumeurs , Carcinome pulmonaire à petites cellules/épidémiologie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Marqueurs biologiques tumoraux/génétique , Carcinome pulmonaire non à petites cellules/diagnostic , Carcinome pulmonaire non à petites cellules/mortalité , Carcinome pulmonaire non à petites cellules/chirurgie , République tchèque/épidémiologie , Anciens fumeurs , Femelle , Humains , Tumeurs du poumon/diagnostic , Tumeurs du poumon/mortalité , Tumeurs du poumon/chirurgie , Mâle , Adulte d'âge moyen , Mutation , Stadification tumorale , Pneumonectomie , Études prospectives , Enregistrements , Carcinome pulmonaire à petites cellules/diagnostic , Carcinome pulmonaire à petites cellules/mortalité , Carcinome pulmonaire à petites cellules/thérapie , Fumeurs , Facteurs temps , Résultat thérapeutique , Jeune adulte
4.
G3 (Bethesda) ; 11(4)2021 04 15.
Article de Anglais | MEDLINE | ID: mdl-33570581

RÉSUMÉ

DNA damages that hinder the movement of the replication complex can ultimately lead to cell death. To avoid that, cells possess several DNA damage bypass mechanisms. The Rad18 ubiquitin ligase controls error-free and mutagenic pathways that help the replication complex to bypass DNA lesions by monoubiquitylating PCNA at stalled replication forks. In Saccharomyces cerevisiae, two of the Rad18 governed pathways are activated by monoubiquitylated PCNA and they involve translesion synthesis polymerases, whereas a third pathway needs subsequent polyubiquitylation of the same PCNA residue by another ubiquitin ligase the Rad5 protein, and it employs template switching. The goal of this study was to dissect the regulatory role of the multidomain Rad18 in DNA damage bypass using a structure-function based approach. Investigating deletion and point mutant RAD18 variants in yeast genetic and yeast two-hybrid assays we show that the Zn-finger of Rad18 mediates its interaction with Rad5, and the N-terminal adjacent region is also necessary for Rad5 binding. Moreover, results of the yeast two-hybrid and in vivo ubiquitylation experiments raise the possibility that direct interaction between Rad18 and Rad5 might not be necessary for the function of the Rad5 dependent pathway. The presented data also reveal that yeast Rad18 uses different domains to mediate its association with itself and with Rad5. Our results contribute to better understanding of the complex machinery of DNA damage bypass pathways.


Sujet(s)
Protéines de Saccharomyces cerevisiae , Saccharomyces cerevisiae , Altération de l'ADN , Helicase/métabolisme , Réparation de l'ADN , Réplication de l'ADN , Protéines de liaison à l'ADN , Antigène nucléaire de prolifération cellulaire/génétique , Antigène nucléaire de prolifération cellulaire/métabolisme , Saccharomyces cerevisiae/génétique , Saccharomyces cerevisiae/métabolisme , Protéines de Saccharomyces cerevisiae/génétique , Protéines de Saccharomyces cerevisiae/métabolisme , Ubiquitin-protein ligases/génétique , Ubiquitin-protein ligases/métabolisme , Zinc
5.
Sci Rep ; 10(1): 7345, 2020 04 30.
Article de Anglais | MEDLINE | ID: mdl-32355292

RÉSUMÉ

Artificial simplification of bacterial genomes is thought to have the potential to yield cells with reduced complexity, enhanced genetic stability, and improved cellular economy. Of these goals, economical gains, supposedly due to the elimination of superfluous genetic material, and manifested in elevated growth parameters in selected niches, have not yet been convincingly achieved. This failure might stem from limitations of the targeted genome reduction approach that assumes full knowledge of gene functions and interactions, and allows only a limited number of reduction trajectories to interrogate. To explore the potential fitness benefits of genome reduction, we generated successive random deletions in E. coli by a novel, selection-driven, iterative streamlining process. The approach allows the exploration of multiple streamlining trajectories, and growth periods inherent in the procedure ensure selection of the fittest variants of the population. By generating single- and multiple-deletion strains and reconstructing the deletions in the parental genetic background, we showed that favourable deletions can be obtained and accumulated by the procedure. The most reduced multiple-deletion strain, obtained in five deletion cycles (2.5% genome reduction), outcompeted the wild-type, and showed elevated biomass yield. The spectrum of advantageous deletions, however, affecting only a few genomic regions, appears to be limited.


Sujet(s)
Escherichia coli/génétique , Génome bactérien/génétique , Délétion de gène
6.
ACS Synth Biol ; 7(11): 2656-2664, 2018 11 16.
Article de Anglais | MEDLINE | ID: mdl-30351909

RÉSUMÉ

Escherichia coli is a well-established and popular host for heterologous expression of proteins. The preference in the choice of synonymous codons (codon bias), however, might differ for the host and the original source of the recombinant protein, constituting a potential bottleneck in production. Codon choice affects the efficiency of translation by a complex and poorly understood mechanism. The availability of certain tRNA species is one of the factors that may curtail the capacity of translation. Here we provide a tRNA-overexpressing strategy that allows the resolution of the codon bias, and boosts the translational capacity of the popular host BL21(DE3) when rare codons are encountered. In the BL21(DE3)-derived strain, called SixPack, copies of the genes corresponding to the six least abundant tRNA species have been assembled in a synthetic fragment and inserted into a rRNA operon. This arrangement, while not interfering with the growth properties of the new strain, allows dynamic control of the transcription of the extra tRNA genes, providing significantly elevated levels of the rare tRNAs in the exponential growth phase. Results from expression assays of a panel of recombinant proteins of diverse origin and codon composition showed that the performance of SixPack surpassed that of the parental BL21(DE3) or a related strain equipped with a rare tRNA-expressing plasmid.


Sujet(s)
Escherichia coli/génétique , Biosynthèse des protéines/génétique , Codon , Escherichia coli/métabolisme , Édition de gène/méthodes , ARN ribosomique/génétique , ARN de transfert/métabolisme , Protéines recombinantes/biosynthèse
7.
Mol Biol Evol ; 33(5): 1257-69, 2016 05.
Article de Anglais | MEDLINE | ID: mdl-26769030

RÉSUMÉ

Why are certain bacterial genomes so small and compact? The adaptive genome streamlining hypothesis posits that selection acts to reduce genome size because of the metabolic burden of replicating DNA. To reveal the impact of genome streamlining on cellular traits, we reduced the Escherichia coli genome by up to 20% by deleting regions which have been repeatedly subjects of horizontal transfer in nature. Unexpectedly, horizontally transferred genes not only confer utilization of specific nutrients and elevate tolerance to stresses, but also allow efficient usage of resources to build new cells, and hence influence fitness in routine and stressful environments alike. Genome reduction affected fitness not only by gene loss, but also by induction of a general stress response. Finally, we failed to find evidence that the advantage of smaller genomes would be due to a reduced metabolic burden of replicating DNA or a link with smaller cell size. We conclude that as the potential energetic benefit gained by deletion of short genomic segments is vanishingly small compared with the deleterious side effects of these deletions, selection for reduced DNA synthesis costs is unlikely to shape the evolution of small genomes.


Sujet(s)
Transfert horizontal de gène , Taille du génome , Génome bactérien , Évolution biologique , Escherichia coli/génétique , Évolution moléculaire , Gènes bactériens , Phylogenèse
8.
Nucleic Acids Res ; 43(3): 1783-94, 2015 Feb 18.
Article de Anglais | MEDLINE | ID: mdl-25618851

RÉSUMÉ

Ribosomal RNA (rrn) operons, characteristically present in several copies in bacterial genomes (7 in E. coli), play a central role in cellular physiology. We investigated the factors determining the optimal number of rrn operons in E. coli by constructing isogenic variants with 5-10 operons. We found that the total RNA and protein content, as well as the size of the cells reflected the number of rrn operons. While growth parameters showed only minor differences, competition experiments revealed a clear pattern: 7-8 copies were optimal under conditions of fluctuating, occasionally rich nutrient influx and lower numbers were favored in stable, nutrient-limited environments. We found that the advantages of quick adjustment to nutrient availability, rapid growth and economic regulation of ribosome number all contribute to the selection of the optimal rrn operon number. Our results suggest that the wt rrn operon number of E. coli reflects the natural, 'feast and famine' life-style of the bacterium, however, different copy numbers might be beneficial under different environmental conditions. Understanding the impact of the copy number of rrn operons on the fitness of the cell is an important step towards the creation of functional and robust genomes, the ultimate goal of synthetic biology.


Sujet(s)
Escherichia coli/génétique , Évolution moléculaire , Dosage génique , Génie génétique , Opéron , ARN ribosomique/génétique
9.
Vet Immunol Immunopathol ; 152(1-2): 28-36, 2013 Mar 15.
Article de Anglais | MEDLINE | ID: mdl-23084343

RÉSUMÉ

Mammalian host organisms live their life constantly interacting with pathogenic and non-pathogenic Gram-negative bacteria. Commensal/symbiont strains are tolerated in the gut, while pathogens are kept at bay by the immune system. In contrast both commensals and pathogenic bacteria are targets of the immune system outside of the digestive system. Immune cells are activated upon contact with different constituents of bacterial cells like peptidoglycan, outer membrane proteins, fimbriae, bacterial DNA, etc. One of the dominant molecular targets affecting the immune cells is the lipopolysaccharide (LPS), an essential molecule of the cell wall of Gram-negative bacteria. In this review we discuss interactions of macrophages with the main LPS moieties lipid A, core and O-antigen regions.


Sujet(s)
Bactéries à Gram négatif/immunologie , Lipide A/immunologie , Macrophages/immunologie , Antigènes O/immunologie , Récepteurs de reconnaissance de motifs moléculaires/immunologie , Animaux , Humains , Immunité innée
10.
Biochem Biophys Res Commun ; 389(1): 46-51, 2009 Nov 06.
Article de Anglais | MEDLINE | ID: mdl-19699180

RÉSUMÉ

Lipopolysaccharide (LPS) is the main component of Gram-negative bacteria that - upon infection - activates the host immune system and is crucial in fighting pathogens as well as in the induction of sepsis. In the present study we addressed the question whether the key structural components of LPS equally take part in the activation of different macrophage immune responses. By genomic modifications of Escherichia coli MG1655, we constructed a series of strains harboring complete and truncated forms of LPS in their cell wall. These strains were exposed to RAW 264.7 macrophages, after which phagocytosis, fast release of pre-synthesized TNF and activation of NF-kappaB signal transduction pathway were quantified. According to our results the core and lipid A moieties are involved in immune recognition. The most ancient part, lipid A is crucial in evoking immediate TNF release and activation of NF-kappaB. The O-antigen inhibits phagocytosis, leading to immune evasion.


Sujet(s)
Escherichia coli/immunologie , Lipopolysaccharides/immunologie , Macrophages/immunologie , Animaux , Lignée cellulaire , Escherichia coli/génétique , Génome bactérien , Lipide A/génétique , Lipide A/immunologie , Lipopolysaccharides/génétique , Macrophages/microbiologie , Souris , Facteur de transcription NF-kappa B/biosynthèse , Antigènes O/génétique , Antigènes O/immunologie , Phagocytose/immunologie , Facteur de nécrose tumorale alpha/biosynthèse
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE